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Abstract
Background—Clinical guidelines recommend breast conserving surgery (BCS) with radiation as
a viable alternative to mastectomy for treatment of early-stage breast cancer. Yet, Asian
Americans (AA) are more likely than other groups to have mastectomy or omit radiation after
BCS.
Methods—We applied polytomous logistic regression and recursive partitioning (RP) to analyze
factors associated with mastectomy, or BCS without radiation, among 20,987 California AAs
diagnosed with stage 0–II breast cancer from 1990–2007.
Results—The percentage receiving mastectomy ranged from 40% among US-born Chinese to
58% among foreign-born Vietnamese. Factors associated with mastectomy included tumor
characteristics such as larger tumor size, patient characteristics such as older age and foreign
birthplace among some AA ethnicities, and additional factors including hospital (smaller hospital
size, not NCI cancer center, low socioeconomic status (SES) patient composition, and high
hospital AA patient composition) and neighborhood characteristics (ethnic enclaves of low SES).
These hospital and neighborhood characteristics were also associated with BCS without radiation.
Through RP, the highest mastectomy subgroups were defined by tumor characteristics such as size
and anatomic location, in combination with diagnosis year and nativity.
Conclusions—Tumor characteristics and, secondarily, patient, hospital and neighborhood
factors, are predictors of mastectomy and omission of radiation following BCS among AAs.
Impact—By focusing on interactions among patient, hospital, and neighborhood factors in the
differential receipt of breast cancer treatment, our study identifies subgroups of interest for further
study, and translation into public health and patient-focused initiatives to ensure that all women
are fully informed about treatment options.
INTRODUCTION
Breast conserving surgery (BCS) with radiation has been considered a viable alternative
treatment to mastectomy for most women with early stage breast cancer since the 1990 NIH
Consensus Conference (1, 2) because of evidence that women who undergo BCS with
radiation experience equivalent overall survival compared to mastectomy (3–8). BCS with
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radiation may offer advantages for cosmetic outcomes, potentially mitigating psychosocial
sequelae (9), but generally involves 5 to 7 weeks of postoperative radiation, which, among
other factors, may influence a patient to choose mastectomy over BCS with radiation (10).
BCS without radiation increases risk of local recurrence and mortality (8, 11–13) and is
considered non-guideline treatment (2); the exception is women ≥70 years of age diagnosed
with stage I, hormone receptor (HR) positive breast cancer, and on hormonal therapy, where
BCS without radiation may be considered accepted treatment (14). Despite the demonstrated
benefits of BCS with radiation, prior research based in representative cancer registry data
has shown that Asian American (AA) women are considerably more likely than other racial/
ethnic groups to have mastectomy (15–18) as well non-receipt of radiation after BCS (17).
Factors that have been associated with choice or use of BCS with radiation over mastectomy
include: younger age (19, 20), smaller tumor size and lack of nodal involvement (21, 22),
shorter travel distance to radiation facility (23, 24), higher socioeconomic status (SES) (25,
26), physician preference (27–29), and later years of diagnosis (25, 30). Patient involvement
with the decision-making process has been associated with both BCS with radiation and
mastectomy (10, 31, 32). It is unclear the extent to which these or other factors influence
treatment for early-stage breast cancer among AA women. Compared to non-Hispanic
White women, the odds of receiving BCS have been shown to be lower among foreign-born
AA women than among US-born AA women (33). Another US study based on 82 Chinese
breast cancer patients showed that lower SES, foreign birthplace or recent immigration, and
speaking no or limited English were associated with mastectomy (34), and a population-
based study showed that adjustment for hospital and provider characteristics explained a
substantial proportion of the higher odds of mastectomy among Vietnamese women
compared to White women (16). A recent study of women in Tianjin, China, showed that
patient SES and insurance status, rather than tumor characteristics, were primary factors
driving mastectomy over BCS with radiation (35). A survey of providers in the San
Francisco Bay Area who treat AA breast cancer patients showed that tumor-to-breast ratios,
patients’ attitudes toward preserving the breast, cultural factors, and transportation
difficulties were perceived to be important factors in the higher rates of mastectomy in this
population (36).
Therefore, in six AA ethnic groups, we set out to identify factors associated with receipt of
mastectomy or BCS omitting radiation in the large, population-based Surveillance,
Epidemiology, and End Results (SEER) California Cancer Registry (CCR) dataset enhanced
with the ability to assess immigrant status, neighborhood factors including SES and ethnic
enclave, and hospital characteristics. In addition to polytomous regression in our
observational study, we also apply recursive partitioning (RP) to identify and clustered
subgroups with the highest receipt of mastectomy or omission of radiation following BCS.
MATERIALS AND METHODS
Study Population
We identified from the CCR all Chinese, Japanese, Filipina, Korean, South Asian, or
Vietnamese women diagnosed with a first primary, AJCC stage 0-II breast cancer in
California from January 1, 1990 to December 31, 2007 (N=23,982). These six AA groups
represented 91% of all AA and Native Hawaiian, Pacific Islander (NHPI) breast cancer
patients. We excluded tumors for which BCS with radiation is contraindicated (37),
including lobular carcinoma in-situ (38), tumors greater than 5 cm (39), microscopic tumor
foci (15), inflammatory carcinoma (2), and diffuse tumors (2). Further, we excluded women
diagnosed on death certificate/autopsy only and cases that were not microscopically
confirmed (resulting N=21,146). We also excluded women with bilateral tumors or
unknown laterality, unknown nodal involvement, subcutaneous mastectomy, extent of
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surgery unknown, or no surgical treatment (resulting N=20,987). It was not possible to
exclude multifocal tumors given inconsistencies in its coding in the registry over time.
Treatment and tumor characteristics
The registry data contain information for the first course of most extensive cancer treatment,
considered treatment administered or initiated within the first four (cases diagnosed 1990–
1997) or 12 months following diagnosis (cases diagnosed 1998–2007). BCS includes partial
mastectomy, not otherwise specified (NOS); partial mastectomy with nipple resection; less
than total mastectomy, NOS; lumpectomy or excisional biopsy; reexcision of biopsy site for
residual disease; and segmental mastectomy (including wedge resection, quadrantectomy,
tylectomy). Cases were categorized as having received mastectomy (N=10,431); BCS with
radiation (N=7,792) (40) (defined as BCS with radiation (N=7,590) or BCS without
radiation in older women (≥70 years) with stage I, HR positive breast cancer (N=202) (14));
or BCS without radiation (this excludes older women in the prior group) (N=2764). Cancer
registry data on tumor characteristics, including those shown in Table 1, are routinely
abstracted by tumor registrars (41). HR status was coded as positive if the tumor was
estrogen- and/or progesterone-receptor positive, negative if the tumor was both estrogen-
and progesterone-receptor negative, and unknown for the remainder; unknown HR status
was more common in earlier years of diagnoses.
Patient- and neighborhood-level immigrant and SES characteristics
Because the ~30% of AA patients in the cancer registry with unknown birthplace data are
more likely to be US-born than those with available data (33, 42-44), we applied a validated
method based on patients’ Social Security numbers (SSN) to classify patient immigrant
status for patients with unknown data, as described previously (45).
We used residential address and 1990 (for cases diagnosed 1990–1995) and 2000 (for cases
diagnosed 1996+) Census block group-level data to classify neighborhood SES and Asian
ethnic enclave status. We assigned neighborhood SES using a previously described index
(46) that incorporates data on education, income, occupation, and housing costs. An ethnic
enclave is an area that maintains more cultural mores and is ethnically distinct from the
surrounding area (47), and is based on an index that includes Census data on Asian race/
ethnicity, language, nativity, and recency of immigration (48). Both neighborhood-level
indices were classified into quintiles based on their distributions in California, then re-
categorized into two groups because of small sample sizes in the quintiles. Because
neighborhood SES and ethnic enclave status are correlated, we defined block groups jointly
by neighborhood SES and ethnic enclave.
Hospital characteristics
Information on total number of hospital beds, as an indicator of size, was obtained from the
2001 California Office of Statewide Health Planning and Development hospital utilization
file (49). In addition, we calculated the percent of AA and NHPI cancer cases reported by
each hospital for the years 1990–2007. Hospitals were then dichotomized on whether this
percent was above or below the median (10%) for all reporting hospitals statewide.
Similarly, hospitals were dichotomized on whether at least 25% of cancer patients reported
by that hospital were in the upper neighborhood SES quintile.
Data analysis
Multivariable, polytomous logistic regression models were used to calculate odds ratios
(ORs) and 95% confidence intervals (CIs) for the association of treatment (receipt of
mastectomy or BCS omitting radiation, relative to receipt of BCS with radiation) with
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patient, neighborhood, and hospital characteristics. We adjusted for clustering by hospital
and by block group simultaneously. Statistical analyses were performed using SAS 9.2 (SAS
Institute Inc., Cary, NC); logistic regression was conducted using PROC
SURVEYLOGISTIC.
RP, conducted using the RPART routine in R (50), was used to identify mutually exclusive
subgroups that varied with regard to the probably of receiving mastectomy, or BCS omitting
radiation, relative to BCS with radiation (50–54). RP is a non-parametric regression method
used to find the decision tree with the lowest average misclassification rate for classifying
future observations; it is particularly useful for identifying multi-way interactions among
variables, and clustered subgroups. We constructed one tree modeling the probability of
mastectomy versus BCS with radiation, excluding women who had received BCS omitting
radiation, and a second tree modeling BCS with radiation versus BCS omitting radiation,
excluding women who underwent mastectomy. The same explanatory variables and
categories that were used in the regression analyses were submitted into the RP procedures.
RESULTS
Among 20,987 AA women diagnosed with stage 0-II breast cancer between 1990–2007 and
eligible for BCS with radiation, 37.2% received BCS with radiation; 49.7% received
mastectomy; and 13.2% received BCS with omission of radiation (Table 1).
In multivariate logistic regression analyses, women age 60 and older were more likely than
younger age groups to receive mastectomy (Table 2). Compared to US-born Japanese, US-
born Korean, and foreign-born Korean, Chinese, Filipina and Vietnamese were more likely
to receive mastectomy. Modeled as a linear variable (as opposed to categorical variable as
shown in Table 2), successive increases in single year of diagnosis were associated with
lower odds of receiving mastectomy (OR=0.94, 95% CI 0.94–0.95). Compared to women
diagnosed in 1990, women diagnosed after 2001 were approximately half as likely to
receive a mastectomy. Tumor size was the most important clinical predictor of mastectomy;
compared to women with <1 cm tumors, women with tumor size 4–5 cm were over 6 times
more likely to receive a mastectomy. Histology, grade, HR status, nodal involvement, and
anatomic location of the tumor were also associated with mastectomy, as were hospital
characteristics including smaller hospital size, non-NCI cancer center, low hospital SES
patient composition, and high hospital AA patient composition. Women residing in low SES
ethnic enclaves were more likely to undergo mastectomy than those in high SES, less Asian
ethnic neighborhoods.
Successive increases in single year of diagnosis were associated with 5% increases in BCS
omitting radiation (Table 2). Tumor characteristics including larger tumor size, DCIS or
unknown histology, unknown grade, HR status negative, and multifocal or NOSanatomic
site were associated with BCS omitting radiation; however, as discussed below, these
associations with clinical characteristics need to be interpreted with caution as they may
reflect underascertainment of radiation therapy. BCS omitting radiation was also more likely
among AA women living in low SES, ethnic enclave neighborhoods, and women diagnosed
in hospitals that were smaller, and with relatively lower patient SES and higher composition
of AAs.
The RP tree modeling mastectomy versus BCS with radiation (Figure 1 and Table 3)
revealed 11 mutually-exclusive subgroups with tumor size being the most important
predictor, as indicated by the first tree split. Year of diagnosis and anatomic location were
also featured prominently on the RP tree. The subgroups with the highest proportion of
mastectomy (71.8%) were AA women in nodes 1 with ≥2 cm tumors, a subgroup that
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represented 53% of the total sample. Nodes 2–3 were women with tumors <2 cm, but with
multifocal or NOS location of the tumor (node 2, 64.9% mastectomy), or foreign-born
Chinese, Filipina, Vietnamese, or US-born Japanese, Korean, Vietnamese diagnosed before
1996 (node 3, 64.7% mastectomy). In contrast, the node with the lowest percent mastectomy
(node 5, 35% mastectomy) included AA women with tumors <2 cm, tumor mass confined
within one quadrant or were overlapping lesions, and diagnosed in the latter part of the study
period, between 2003–2007. There were no splits by hospital nor by neighborhood
characteristics.
The RP tree modeling BCS omitting radiation versus BCS with radiation revealed that
known versus unknown HR status (primarily reflective of calendar year) was the most
important predictor (data not shown). Among women with HR positive and negative tumors,
21% omitted radiation, and there were no additional splits after this node. For women with
unknown HR status, three subgroups had high proportions (>60%) of omission of radiation:
1) those with grade I-II tumors in public hospitals with relatively higher proportions of
Asians; 2) those aged 75 or older with DCIS in hospitals with relatively fewer Asians; and
3) Koreans, foreign-born Vietnamese, and US-born South Asians aged less than 75 with
DCIS in hospitals with relatively fewer Asians.
DISCUSSION
AAs are among the most rapidly growing racial/ethnic populations in the US and
particularly in California, where more than one-third of all US AAs reside (55–59). Breast
cancer is the most commonly diagnosed cancer among AA women, and incidence rates are
higher in the US compared to most cancer registries in Asia (60). Rates have been found to
be increasing over time among US AA women - rates of invasive breast cancer were 104 per
100,000 in 1988–1994 among Californian US-born AA women, and 136 per 100,000 in
2000–2004; among foreign-born, rates for these same time periods were 71 and 79,
respectively; annual percentage changes were as high as 4% per year among US-born
Filipinas and foreign-born Koreans (45). Since the 1990 Consensus Conference (2), BCS
with radiation has steadily increased in general, but AA women are considerably less likely
to have BCS with radiation and more likely to omit radiation after BCS (18, 61). Taking
advantage of a large, population-based cancer registry enhanced with patient-level
immigrant status, neighborhood characteristics including SES and ethnic enclave (62), as
well as hospital characteristics, this report contributes new insights into patterns of treatment
for early-stage breast cancer among six large ethnic populations of AA women. Our study
found that although tumor characteristics are the most important predictors of treatment,
patient race/ethnicity and nativity, and hospital and neighborhood SES and racial/ethnic
composition, are also important determinants.
In addition to traditional logistic regression, we used RP to identify interactions among
patient, hospital and neighborhood factors, and discrete subgroups of AA women with
varying proportions of mastectomy or BCS without radiation. Our results indicate that some
factors that were independently significant in logistic regression analyses did not feature in
the RP trees, suggesting that their independent effects in the total sample were not seen in
more discrete patient subgroups. Our finding that clinical factors, such as tumor size and
anatomic location, are most important in the mastectomy decision tree is consistent with
clinical practice guidelines (37); yet, the high rates of mastectomy among AA women with
even moderate-sized tumors (2–5 cm) suggests that high tumor-to-breast ratio is likely an
important consideration for these women. The appearance of year of diagnosis as an
important factor in the decision tree likely reflects temporal changes in the adoption of
treatment recommendations since the original NIH Consensus Conference (2), as examined
previously (25).
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AA ethnicity and nativity were also predictors of mastectomy receipt among women
diagnosed over the same time period with tumors less than 2 cm. Given the same tumor
characteristics, specific AA ethnicities differed by nativity in the extent to which they
underwent mastectomy. In decision tree analyses, foreign-born Chinese, Filipina, and
Vietnamese had high rates of mastectomy, despite small tumor sizes, while foreign-born
Japanese and South Asians, who tend to be English-speaking and more acculturated, even
when foreign-born, had low mastectomy rates. These findings are reflective of cultural and
immigrant/language factors playing a strong role, and consistent with previous findings (31,
34, 36, 63). Thus, besides being a powerful tool for informing further research to identify
underlying reasons for these treatment differences, the RP results can be used by providers
and hospitals to develop programs and initiatives, such as patient navigators, cultural
competency provider training, and availability of translators, that may be implemented
within their institutions to ensure that all women are informed of their treatment options.
Results from our qualitative study (unpublished) indicated that low SES AA women who
were linguistically isolated were often not informed about their treatment choices; however,
within one community (San Francisco Chinatown), community and hospital patient
navigator programs were extremely successful in helping the Chinese residents receive BCS
with radiation, if desired, by providing transportation, translation, appointment scheduling,
and overall navigation services.
To our knowledge, no previous study has evaluated breast cancer surgical treatment type
among AA subgroups over an 18-year time interval. We found a trend of decreasing rates of
mastectomy, consistent with prior reports (25). In an additional analysis (data not shown),
we found increasing rates of BCS with omission of radiation since 1990 in women with
stage I-II tumors, but not DCIS tumors, and these trends were more pronounced for cases
who also received chemotherapy, for reasons that are unclear, but warrant further
investigation. This may be because the standard order of therapies (BCS, chemotherapy for
4-6 months, then radiation) pushes radiation outside of the timeframe in which treatment
data are collected by the registry.
Our finding of increased rates of BCS omitting radiation supports a growing body of work
(64). Previously implicated predictors for radiation omission following BCS include older
age, negative nodes, larger hospital size, tumors greater than 2 cm, geographic location, and
race (19, 23, 65–70). In our study, although variations by AA ethnicity and nativity were not
statistically significant, neighborhood and hospital race/ethnicity composition and SES were
significantly associated with omission of radiation after BCS.
However, our results may be impacted by the under-ascertainment of radiation in the cancer
registry, particularly if there are delays in the administration of radiation (71). While a
recent report found a 32% under-ascertainment of radiation compared to self-report in the
Los Angeles SEER registry, one of the registries included in the current analysis, a
comparison of SEER and Medicare claims data showed that agreement on radiation was
94% (kappa = 87%) and under-ascertainment by SEER was 7% (72). In the report based on
Los Angeles SEER registry data, radiation under-ascertainment was significantly higher
among patients with the following characteristics: White race, more advanced stage,
younger age, lower income, Medicare or no insurance, had mastectomy, received
chemotherapy, had (self-reported) delays in initiation of radiation, and diagnosed in non-
ACoS (American College of Surgeons) hospitals (~40% of California hospitals) (73). As
under-ascertainment was more likely among patients of lower SES, this may have over-
estimated our findings for the associations we found with neighborhood and hospital
characteristics. In particular, the association of clinical characteristics with omission of
radiation following BCS should be interpreted with caution; they may be reflective of this
under-ascertainment of radiation considering that receipt of chemotherapy is a factor
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associated with missing data on radiation, and patients with worse prognosis/higher stage are
more likely to have received a recommendation for chemotherapy. Our study also has
several other potential limitations. We opted to include all stage 0-II tumors, rather than
invasive tumors only. Although there has been debate about whether BCS with radiation is
the preferred treatment for DCIS, a recent study showed excellent long-term prognosis for
both invasive and DCIS tumors (12). Our time trend results were unchanged when we
excluded DCIS from our analysis. Our RP analysis was not a concern in this regard, given
that RP will naturally discriminate on DCIS/ invasive classification. However, one limitation
involved in analyses utilizing RP is potential instability in resultant trees that occurs due to
the method RP uses of within-population sampling. In addition, it is possible that a
proportion of women with breast site NOS or multifocal (n=2,125) may have had multifocal
disease and thus have contraindications for BCS with radiation (2). Our polytomous logistic
regression results were not substantively altered when excluding these women, and RP
naturally discriminates on breast site to identify the most homogeneous subgroups for this
variable. Our results may also be affected by the observational nature and inherent data
limitations in cancer registry data. Since registry data on surgery captures the most extensive
surgical resection, we are unable to consider women who may have had repeated
lumpectomies and unclear margins, and who may opt for mastectomy to avoid further
repeated surgeries. In addition, we are unable to consider contraindications to BCS with
radiation or radiation due to the lack of comorbidity and other patient-level data (19). The
lack of data on language and insurance status is an additional limitation. Finally, our study
lacks reliable data on breast reconstruction, and the ability to differentiate those who had
mastectomy with reconstruction versus mastectomy only. Given that reconstruction can
address many of the psychological impacts of mastectomy alone (74), and, especially when
available concurrently with mastectomy, may influence a woman’s decision to choose
mastectomy over BCS. However, rates of (self-reported) reconstruction from a previous
study were very low (only 1 of 21 Asian women who received mastectomy also received
reconstruction), and thus unlikely to greatly impact the findings.
This study has a number of strengths, including the large population-based sample collected
over a protracted time period, which allowed sufficient statistical power to detect moderate
associations and to apply RP. We used RP, a powerful statistical technique to identify
meaningful subgroups of AA most likely to receive mastectomy. Our study is the first, to
our knowledge, to apply RP to a large population-based sample of AA women and identify
ethnicity and nativity as important predictors.
In a population-based sample of AA breast cancer patients, a group with traditionally high
rates of mastectomy, our study shows that immigration, neighborhood and hospital factors
are associated with mastectomy and omission of radiation. Additional research is needed to
understand cultural factors that underlie the decision-making process among AA women, as
well as reasons behind the associations with neighborhood and hospital factors. By focusing
on the interactions of patient, hospital, and neighborhood factors in the differential receipt of
breast cancer treatment, our study identifies subgroups of women for further study, and,
most importantly, results that can be immediately translated into public health and patient-
focused initiatives to ensure that all women, regardless of race/ethnicity, immigrant status,
SES, and language, are fully informed about their treatment options (9).
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Figure 1. Recursive partitioning tree modeling mastectomy versus BCS with radiation, Asian
American Women diagnosed with stage 0–II breast cancer, 1990–2007
Recursive partitioning is a non-parametric regression method that uses the current data set to
find the decision tree with the lowest average misclassification rate for classifying future
observations. The terminal nodes of the tree partition the participants to subgroups according
to a set of explanatory variables. Starting with the original data set, recursive partitioning
splits each node by examining each variable and selecting one binary split across the
members in that node, based on a variable that maximizes the “purity” in the outcome. This
process is repeated until further partitioning is not possible. Because the final tree over-fits
the data, ten-fold cross-validation is used to prune the tree. Finally, the “one-standard error”
heuristic is used to find the simplest tree with a cross-validated error estimate no more than
one standard error larger than the best tree. Recursive partitioning has the ability to detect
multi-way interactions and handle highly correlated variables; alternatively, this method is
less well known and not as powerful as parametric methods when the form of the underlying
model is parametric and correctly specified.
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Table 3
Summary of subgroups identified through recursive partitioning and probability of having mastectomy
Terminal node Risk group characteristics N
Probability of having a
mastectomy (95% CI)
1 Tumor size ≥2 cm 7678 71.8% (70.8%, 72.8%)
2 Tumor size <2 cm. Multifocal or location NOS, or central mass. 1653 64.9% (62.6%, 67.2%)
3 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–1995.
Foreign-born Chinese, Filipina, Vietnamese; US-born Japanese, Korean, Vietnamese.
1126 64.7% (61.9%, 67.4%)
4 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–1995.
Foreign-born Japanese, Korean, South Asian; US-born Chinese, Filipina, South
Asian.
425 46.1% (41.4%, 50.9%)
5 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 2003–2007. 3623 35.0% (33.4%, 36.5%)
6 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Japanese, South Asian; US-born Chinese, Japanese.
1161 36.9% (34.1%, 39.6%)
7 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Chinese, Filipina, Vietnamese; US-born Japanese, Korean, Vietnamese.
Histology DCIS.
284 32.7% (27.3%, 38.2%)
8 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Chinese, Filipina, Vietnamese; US-born Japanese, Korean, Vietnamese.
Histology ductal, invasive, lobular, other. HR status negative, unknown.
668 58.1% (54.3%, 61.8%)
9 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Chinese, Filipina, Vietnamese; US-born Japanese, Korean, Vietnamese.
Histology ductal, invasive, lobular, other. HR status positive. Grades III, IV and
unknown.
426 54.2% (49.5%, 59.0%)
10 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Chinese, Filipina, Vietnamese; US-born Japanese, Korean, Vietnamese.
Histology ductal, invasive, lobular, other. HR status positive. Grades I and II.
122 56.6% (47.8%, 65.4%)
11 Tumor size <2 cm. Mass one quadrant or overlapping lesion. Dx 1990–2002.
Foreign-born Chinese, Filipina, Vietnamese, Korean; US-born Japanese, Korean,
Vietnamese, Filipina. Histology ductal, invasive, lobular, other. HR status positive.
Grades I and II.
1057 41.9% (38.9%, 44.9%)
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